Unlabelled: Intravenous immunoglobulin (IVIG) therapy is a recognized treatment of inflammatory and autoimmune disorders and its efficacy in multiple sclerosis (MS) has been proven in a few double-blind studies. IVIG has several effects on the immune system that could have a beneficial influence on disease process in MS and one of these effects are significant changes in serum levels of circulating cytokines after IVIG infusions. As interleukin-6 (IL-6) and interleukin-10 (IL-10) play important role as pro- and anti-inflammatory factors, in vivo modulation of these cytokines may account for immunomodulatory and anti-inflammatory effect of IVIG therapy. In order to better understand mechanism of action of low-dose IVIG cyclic therapy we have investigated serum levels of IL-6 and IL-10 before and a day after IVIG infusion in patients with MS.
Material And Methods: Serum levels of IL-6 and IL-10 were assayed in 20 patients with MS before and 24 hours after infusion of 2.5 g (n = 9) and 5 g (n = 11) of IVIG.
Results: Significant changes of IL-6 nor IL-10 serum levels after IVIG infusions in both doses of 2.5 g and 5 g were not observed.
Conclusion: Single infusion of 2.5 g nor 5 g of IVIG does not alter serum levels of neither pro-inflammatory IL-6 nor anti-inflammatory IL-10. As modulating influence of IVIG on the serum levels of IL-6 and IL-10 seems to be dose-dependent, further investigations of these cytokines levels after infusions of higher doses of IVIG might be efficient in the assessment of its usability in monitoring of immune system response to IVIG treatment.
Download full-text PDF |
Source |
---|
BMC Pulm Med
January 2025
Department of Respiratory Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto 1-1-1 Honjo, Chuo-ku, 860-8556, Japan.
Background: Fibrotic types of interstitial lung abnormalities seen on high-resolution computed tomography scans, characterised by traction bronchiolectasis/bronchiectasis with or without honeycombing, are predictors of progression and poor prognostic factors of interstitial lung abnormalities. There are no reports on the clinical characteristics of fibrotic interstitial lung abnormalities on high-resolution computed tomography scans. Therefore, we aimed to examine these clinical characteristics and clarify the predictive factors of fibrotic interstitial lung abnormalities on high-resolution computed tomography scans.
View Article and Find Full Text PDFBMC Gastroenterol
January 2025
Department of Nephrology, QingPu Branch of Zhongshan Hospital Affiliated to Fudan University, Shanghai, People's Republic of China.
Background: Gallstone disease (GSD) is associated with obesity. The Cardiometabolic Index (CMI), a metric that accurately assesses central adiposity and visceral fat, has not been extensively studied in relation to GSD risk. This study investigates the link between CMI and GSD incidence in U.
View Article and Find Full Text PDFPediatr Res
January 2025
Department of Pediatrics, Medical College of Wisconsin, Children's Wisconsin, Milwaukee, WI, USA.
Background: The immune heterogeneity of biliary atresia (BA) presents a challenge for development of prognostic biomarkers. This study aimed to identify early immune signatures associated with biliary drainage after Kasai Portoenterostomy (KPE).
Methods: Serum samples, liver slides, and clinical data were obtained from patients enrolled in the NIDDK-supported Childhood Liver Disease Research Network.
Mol Biol Rep
January 2025
Department of Clinical Pathology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Background: The identification of circulating potential biomarkers may help earlier diagnosis of breast cancer, which is critical for effective treatment and better disease outcomes. We aimed to study the role of circ-FAF1 as a diagnostic biomarker in female breast cancer using peripheral blood samples of these patients, and to investigate the relation between circ-FAF1 and different clinicopathological features of the included patients.
Methods And Results: This case-control study enrolled 60 female breast cancer patients and 60 age-matched healthy control subjects.
J Mol Histol
January 2025
Clinical Pharmacology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Type 2 diabetes mellitus (T2DM) adversely affects various organs, including the brain and its blood barrier. In addition to the brain, hyperglycemia damages the testes. The testes possess blood-tissue barriers that share common characteristics and proteins with the blood-brain barrier (BBB), including breast cancer-resistant protein (BCRP).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!